Everspan organizes published research for informational purposes only. This is not medical advice. Consult a healthcare provider before starting any intervention.
Trending
Back to Atlas
T3· AdvancedB+· GoodOtherOther
Cardiovascular

Advanced Lipid Panel (NMR/Ion Mobility)

Research indicates advanced lipid testing methods like NMR and ion mobility provide more detailed cardiovascular risk assessment than standard lipid panels.

Human Trials

15

45,000 participants

Risk Level

Low Risk

Monthly Cost

$100$400 /month

One-time test typically $200-400, recommended annually or biannually

Quick Facts

Category
Other
Research Field
Other
Evidence Grade
B+ – Good
Risk Level
Low
Monthly Cost
$100 – $400
Human Trials
15

Research Velocity

+18%
45 publications in the last 12 months · steady increase in publications

Mechanism of Action

Nuclear magnetic resonance (NMR) and ion mobility technologies measure lipoprotein particle size, number, and density rather than just cholesterol content. These methods provide detailed analysis of LDL and HDL subfractions, allowing identification of small, dense LDL particles and other atherogenic lipoproteins. Research suggests this enhanced characterization may better predict cardiovascular risk and metabolic dysfunction compared to traditional lipid measurements.

Overview

Advanced lipid panel testing using nuclear magnetic resonance (NMR) spectroscopy or ion mobility technology represents a significant evolution beyond traditional cholesterol measurements. Research indicates these methods provide detailed analysis of lipoprotein particle size, number, and density, offering insights that standard lipid panels cannot capture. Studies suggest that measuring LDL particle number and identifying small, dense LDL particles may be more predictive of cardiovascular events than total cholesterol levels alone.

Large-scale studies have demonstrated that NMR lipoproteins can identify individuals at increased cardiovascular risk even when traditional lipid levels appear normal. Research suggests these advanced panels may be particularly valuable for assessing risk in patients with diabetes, metabolic syndrome, or discordant traditional lipid results. The technology also provides detailed HDL subfractions analysis, which studies indicate may help explain the "HDL paradox" where some individuals with high HDL still experience cardiovascular events.

While not yet standard of care, research supports the clinical utility of advanced lipid testing for precision cardiovascular risk assessment. These tests are widely available through major laboratory networks and direct-to-consumer platforms, with costs typically ranging from $200-400 per panel. Studies suggest the additional cardiovascular risk information may justify the higher cost compared to basic lipid panels, particularly for individuals with intermediate risk or those optimizing preventive interventions.

Known Interactions

  • No direct interactions as this is a diagnostic test
  • Results may be affected by recent meals, alcohol consumption, or certain medications
  • Statin therapy can alter lipoprotein particle profiles measured by these methods

Legal Status by Country

📍

Your country (United States)

Available through labs and direct-to-consumer

OTC
✈️

Available without prescription in:

Australia, Brazil, Canada, Germany, Israel, Japan, Mexico, Netherlands, South Korea, Switzerland, UAE, United Kingdom, United States

Australia
OTC
✈️Brazil
OTC
Canada
OTC
Germany
OTC
✈️Israel
OTC
Japan
OTC
✈️Mexico
OTC
Netherlands
OTC
✈️South Korea
OTC
Switzerland
OTC
✈️UAE
OTC
United Kingdom
OTC
📍United States
OTC
China
Varies
✈️Colombia
Varies
✈️India
Varies
✈️Panama
Varies
Russia
Varies
✈️Thailand
Varies
✈️Turkey
Varies

📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.

Key Research

Last verified: 2026-03-19